Marquette University

e-Publications@Marquette
Chemistry Faculty Research and Publications

Chemistry, Department of

2-1-2010

Defining the Structural Consequences of
Mechanism-Based Inactivation of Mammalian
Cytochrome P450 2B4 Using Resonance Raman
Spectroscopy
Piotr J. Mak
Marquette University, piotr.mak@marquette.edu

Haoming Zhang
University of Michigan - Ann Arbor

Paul F. Hollenberg
University of Michigan - Ann Arbor

James R. Kincaid
Marquette University, james.kincaid@marquette.edu

Accepted version. Journal of the American Chemical Society, Vol. 132, No. 5 (February 2010):
1494-1495. DOI. © 2010 American Chemical Society. Used with permission.

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Defining the Structural
Consequences of Mechanism-Based
Inactivation of Mammalian
Cytochrome P450 2B4 Using
Resonance Raman Spectroscopy

Piotr J. Mak
Department of Chemistry, Marquette University,
Milwaukee, WI

Haoming Zhang
Department of Pharmacology, University of Michigan,
Ann Arbor, MI

Paul F. Hollenberg
Department of Pharmacology, University of Michigan,
Ann Arbor, MI

James R. Kincaid
Department of Chemistry, Marquette University,
Milwaukee, WI

Journal of the American Chemical Society, Vol 132, No. 5 (February 2010): pg. 1494-1495. DOI. This article is © American
Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette. American
Chemical Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without
the express permission from American Chemical Society.

1

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Abstract

In view of the potent oxidizing strength of cytochrome P450 intermediates, it
is not surprising that certain substrates can give rise to reactive species
capable of attacking the heme or critical distal-pocket protein residues to
irreversibly modify the enzyme in a process known as mechanism-based (MB)
inactivation, a result that can have serious physiological consequences leading
to adverse drug−drug interactions and toxicity. While methods exist to
document the attachment of these substrate fragments, it is more difficult to
gain insight into the structural basis for the altered functional properties of
these modified enzymes. In response to this pressing need to better
understand MB inhibition, we here report the first application of resonance
Raman spectroscopy to study the inactivation of a truncated form of
mammalian CYP2B4 by the acetylenic inhibitor 4-(tert-butyl)phenylacetylene,
whose activated form is known to attach to the distal-pocket T302 residue of
CYP2B4.

Membrane-bound human cytochromes P450, which are
responsible for catalyzing the metabolism of pharmaceuticals or other
xenobiotics,1 proceed through a complex cycle involving the sequential
delivery of two electrons to a heme-bound dioxygen complex, effecting
the splitting of the O−O bond to generate a potent oxygenating
intermediate capable of inserting a single oxygen atom into the bound
substrates, the nature of the putative intermediate generally being
formulated as a ferryl heme π-cation similar to the Compound I
species in the enzymatic cycles of the heme peroxidases.1 In view of
the impressive oxidizing strength of this species, it is not surprising
that certain substrates give rise to reactive intermediates capable of
attacking the heme or critical distal-pocket protein residues to
irreversibly modify the enzyme in a process known as mechanismbased (MB) inactivation.2 Some of the common compounds that fall
into the category of MB inactivators are acetylenes, organosulfur
compounds, arylamines, and others.2
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Obviously, inasmuch as such irreversible inactivation can have
profound physiological consequences leading to adverse drug−drug
interactions or toxicity, it is important to gain structural insight into
the altered functional behavior of these modified P450s. One of the
most powerful techniques available for this purpose is resonance
Raman (RR) spectroscopy, which is able to provide critical information
about the heme active-site structure, including reliable documentation
of the iron oxidation and spin states3 and the disposition of bound
exogenous ligands, permitting characterization of unstable
intermediates such as the oxy, peroxo, and hydroperoxo intermediates
that arise in the P450 cycle.3-6 In response to the pressing need to
better understand MB inhibition, we here report the first application of
RR to study the inactivation of a truncated form of mammalian CYP2B4
by the acetylenic inhibitor 4-(tert-butyl)phenylacetylene (BPA), whose
activated form is known to attach to the distal-pocket T302 residue of
CYP2B4 (Figure S1 in the Supporting Information).7
The high-frequency RR spectra of the wild-type substrate-free
ferric enzyme (WT 2B4dH SF) and its adduct with the prototypical
substrate benzphetamine (WT 2B4dH BZ) are shown in Figure 1. The
spectrum of the SF sample (trace A) exhibits the oxidation-state
marker mode ν4 at 1372 cm−1 and the ν3 and ν2 spin-state markers at
1502 and 1583 cm−1, respectively, confirming the presence of a ferric
low-spin state.3,8 The addition of BZ (trace B) causes partial spin-state
conversion (seen as an increase in the intensity of the high-spin ν3
mode at 1487 cm−1) associated with disruption of the distal-pocket
water cluster, entirely consistent with the RR data previously reported
for full-length ferric substrate-free and BZ-bound cytochrome 2B4.9
The spectrum of the BPA-modified 2B4dH without added substrate
(modified 2B4dH SF, trace C) exhibits a spectral pattern essentially
identical to that of the WT sample, indicating that the enzyme
modification has no substantial impact on the resting-state heme
structure. The first interesting observation is that addition of substrate
(BZ) to BPA-modified 2B4dH causes no changes in the heme spin state
or macrocyclic core structure, as judged by the virtually identical RR
spectra (traces C and D), the lack of such changes for the modified
form being consistent with the blocking of substrate access by the
attached BPA fragment.7 As shown in Figure S2, the low-frequency RR
spectral data also confirm the lack of significant changes associated
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with the attached fragment and the apparent blocking of BZ access to
the active site.

Figure 1. High-frequency resonance Raman spectra of (A, B) ferric wild-type
cytochrome 2B4 (WT 2B4dH) and (C, D) modified cytochrome 2B4 (modified 2B4dH):
(A, C) substrate-free (SF); (B, D) in the presence of benzphetamine (BZ). All of the
spectra were measured with the 406 nm excitation line at room temperature. Spectra
normalized to the ν4 mode at (A, C, D) 1372 and (B) 1371 cm−1.

It is also of obvious importance to interrogate the ligated forms
of this modified protein. While the oxy and reduced oxy intermediates
are generally quite unstable,1 the stable ferrous CO form is readily
characterized by RR measurements. This form mimics the
physiologically relevant oxy form, providing important information
about the heme moiety and distal side-pocket structure that can affect
ligand−protein interactions.8-16 Figure 2 shows the low-frequency RR
spectra of the CO adducts, where the ν(Fe−CO) stretching and
δ(Fe−C−O) bending modes are observed, and the high-frequency
region containing the ν(C−O) mode. The spectrum of WT 2B4dH SF
exhibits a strong ν(Fe−CO) stretching mode at 471 cm−1 and a
δ(Fe−C−O) bending mode at 558 cm−1 (trace A), with the
corresponding ν(C−O) mode occurring at 1950 cm−1. Addition of BZ
causes a small 2 cm−1 downshift of the ν(Fe−CO) mode (trace B), the
magnitude of the shift being similar to those observed previously in
full-length 2B4;9 the ν(C−O) mode shifts upward slightly to 1953
cm−1. Of greatest significance is the relatively large 6 cm−1 downshift
of the Fe−CO mode observed for modified 2B4 SF (trace C), with the
corresponding ν(C−O) stretching mode being upshifted by 9 cm−1 to
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1959 cm−1; both shifts imply a substantial decrease in distal hemepocket polarity and weakening of any possible H-bonding interactions.
These data provide the first direct spectroscopic evidence that the
fragment is positioned in such a way as to impact the disposition of
bound exogenous ligands, which is presumably also relevant for the
dioxygen adduct and the key peroxo and hydroperoxo fragments.
Finally, the addition of BZ to the modified protein sample (trace D)
does not affect the Fe−CO mode (the difference pattern for the spectra
of the modified protein with and without BZ is featureless), a result
that further supports the conclusion drawn from study of the ferric
forms (Figure 1) that the attached BPA fragment blocks the entrance
of substrate into the heme cavity.

Figure 2. RR spectra of ferrous CO adducts of (A, B) WT and (C, D) modified 2B4dH:
(A, C) substrate-free; (B, D) in the presence of BZ. The spectra were measured with
442 nm excitation at room temperature. The inset shows the inverse correlation
between ν(C−O) and ν(Fe−CO) (diamonds, P450cam;8,13-16 triangles, P450 2B4).

In addition to these changes in the Fe−C−O fragment, careful
spectroscopic interrogation of these samples revealed additional
changes in the “vinyl bending” modes. In the case of WT 2B4dH (trace
A) there are two vinyl bending modes, at 410 and 419 cm−1, whereas
in the spectrum of the modified protein (trace C), there is only one
vinyl bending mode at 418 cm−1, the lower-frequency mode having
apparently shifted to a position near the higher one. Similar behavior
was seen in the high-frequency region, where ν(C═C) stretching
modes are observed: in the spectra of the modified protein, the lowerJournal of the American Chemical Society, Vol 132, No. 5 (February 2010): pg. 1494-1495. DOI. This article is © American
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frequency mode at 1620 cm−1 loses intensity while the mode at 1634
cm−1 gains intensity relative to the spectra of the WT protein (Figure
S3). The lower-frequency vinyl bending and stretching modes are
commonly associated with the in-plane configuration of vinyl groups,
while the higher-frequency bands are associated with out-of-plane
orientations.17 This demonstrated ability to document changes in these
vinyl bending and stretching modes is therefore of special importance,
as the orientation of the vinyl groups with respect to the plane of the
heme macrocyle has been suggested to carry functional significance by
modifying the heme reduction potential and affinity for axial
ligands.18,19
The changes seen in the behavior of the modes of the Fe−C−O
fragment are useful indicators of distal-pocket structure.10-16 The
ν(Fe−CO) and ν(C−O) stretching frequencies in heme proteins usually
follow an inverse correlation that reflects Fe−CO back-bonding, as
shown in the inset of Figure 2.10-16 The magnitudes of such shifts are
influenced by the strength of the trans-proximal ligand bond and the
polarity of the distal-pocket environment, i.e., positive charge
(including H bonding) increases the ν(Fe−CO) frequencies and
decreases the ν(C−O) frequencies along the correlation, while its
elimination has the opposite effect.10-16 The comparison of the newly
obtained data for the CO adducts of modified 2B4 with previously
published data locates the ν(Fe−CO)/ν(C−O) points obtained for the
samples studied here (dotted line, Figure 2 inset) only slightly below
the line previously derived for cytochrome P450cam samples (solid
line, Figure 2 inset); the implied strongly nonpolar environment on the
distal site of the heme moiety is obviously most reasonably associated
with the presence of the attached apolar BPA fragment.
In summary, the acquired RR data confirm that the BPA
modification of 2B4dH protein does not substantially alter the restingstate heme structure but does block the BZ substrate from entrance to
the distal pocket. Most importantly, the present studies of the COligated forms convincingly demonstrate the impressive potential of RR
spectroscopy to effectively document even small structural changes
associated with MB inhibition, including alterations in axial-ligand
disposition, heme macrocycle deformation, and variations in vinyl
group orientation, changes that could potentially lead to differences in
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reduction potential or affinity for axial ligands and impact the stability
of key peroxo and hydroperoxo intermediates.
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